{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:59Z","timestamp":1791583199743,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.taap.2014.01.017","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T16:01:39Z","timestamp":1391097699000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Oxidative stress\/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants"],"prefix":"10.1016","volume":"275","author":[{"given":"Angelique","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brandon Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilee","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh-Anne","family":"Piechta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mark Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jim Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"McMillian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2014.01.017_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e8s","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.taap.2014.01.017_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","article-title":"Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex","volume":"52","author":"Bharadwaj","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0180","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2014.01.017_bb0140","series-title":"Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Seminars in liver disease","first-page":"169","author":"Chitturi","year":"2002"},{"key":"10.1016\/j.taap.2014.01.017_bb0185","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2014.01.017_bb0045","series-title":"Covalent Drug\u2013Protein Adducts: An Exploration of Their Role in Drug-Induced Liver and General Organ Toxicity, Encyclopedia of Drug Metabolism and Interactions","author":"Evans","year":"2011"},{"key":"10.1016\/j.taap.2014.01.017_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0205","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0192623312447542","article-title":"Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse","volume":"40","author":"Foster","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.01.017_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1360-0443.2004.00597.x","article-title":"Does disulfiram have a role in alcoholism treatment today?","volume":"99","author":"Fuller","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.taap.2014.01.017_bb0175","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1345\/aph.1E007","article-title":"Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity?","volume":"38","author":"Garc\u00eda-Cort\u00e9s","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.taap.2014.01.017_bb0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)36867-3","article-title":"The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat","volume":"282","author":"Gill","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2014.01.017_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002093-199806000-00007","article-title":"Safety of tacrine: clinical trials, treatment IND, and postmarketing experience","volume":"12","author":"Gracon","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.taap.2014.01.017_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2014.01.017_bb0200","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/106002809202600607","article-title":"Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity","volume":"26","author":"Hagley","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.taap.2014.01.017_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/03602532.2011.645578","article-title":"Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development","volume":"44","author":"Hill","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2014.01.017_bb0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0891-5849(94)E0123-Z","article-title":"A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole","volume":"18","author":"Iuliano","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2014.01.017_bb0150","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1124\/dmd.108.020370","article-title":"Bioactivation of flutamide metabolites by human liver microsomes","volume":"36","author":"Kang","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2014.01.017_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2014.01.017_bb0085","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/01926230290166724","article-title":"Invited review: oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification","volume":"30","author":"Kohen","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.01.017_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pharmthera.2012.09.008","article-title":"Dietary phytochemicals and cancer prevention: nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression","volume":"137","author":"Lee","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2014.01.017_bb0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/tx600351g","article-title":"Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression","volume":"20","author":"Leone","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cbi.2004.09.008","article-title":"Accurate prediction of human drug toxicity: a major challenge in drug development","volume":"150","author":"Li","year":"2004","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2014.01.017_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.103.054288","article-title":"Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats","volume":"307","author":"Luyendyk","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2014.01.017_bb0065","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.bcp.2004.08.003","article-title":"A gene expression signature for oxidant stress\/reactive metabolites in rat liver","volume":"68","author":"McMillian","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.017_bb0080","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.bcp.2004.01.029","article-title":"Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver","volume":"67","author":"McMillian","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.017_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.taap.2005.02.031","article-title":"Drug-induced oxidative stress in rat liver from a toxicogenomics perspective","volume":"207","author":"McMillian","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.017_bb0215","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/tx300341r","article-title":"Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats","volume":"25","author":"Metushi","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1478-3231.2007.01549.x","article-title":"Suspected cross-hepatotoxicity of flutamide and cyproterone acetate","volume":"27","author":"Miquel","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.taap.2014.01.017_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.109.027797","article-title":"A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding","volume":"37","author":"Nakayama","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2014.01.017_bb0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2014.01.017_bb0095","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mc.20205","article-title":"Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity","volume":"45","author":"Nie","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.taap.2014.01.017_bb0060","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1021\/tx800161s","article-title":"Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose","volume":"21","author":"Obach","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.017_bb0165","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2014.01.017_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2011.10.020","article-title":"Species-specific toxicity of troglitazone on rats and human by gel entrapped hepatocytes","volume":"258","author":"Shen","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.017_bb0135","series-title":"Adverse Drug Reactions","first-page":"165","article-title":"Role of reactive metabolites in drug-induced hepatotoxicity","author":"Srivastava","year":"2010"},{"key":"10.1016\/j.taap.2014.01.017_bb0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0130","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2014.01.017_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: current understanding","volume":"47","author":"Uetrecht","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2014.01.017_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2008.02.001","article-title":"Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s","volume":"173","author":"Wen","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2014.01.017_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/DMR-200028812","article-title":"Drug bioactivation covalent binding to target proteins and toxicity relevance","volume":"37","author":"Zhou","year":"2005","journal-title":"Drug Metab. Rev."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:22:23Z","timestamp":1746123743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X14000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0041008X14000258"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2014.01.017","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress\/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2014.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}